Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

US Patent 11497772 · Granted Nov 15, 2022

Estimated economic value: $10,299,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule stimulators of steroid receptor coactivator-3 and methods of thei2025
Small molecule stimulators of steroid receptor coactivator-3 and methods of thei2025
Small molecule stimulators of steroid receptor coactivator-3 and methods of thei2023
Small molecule stimulators of steroid receptor coactivator-3 and methods of thei2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023
Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the tr2023